A companion diagnostic is a medical device, most commonly an in vitro device, that gives information necessary for the safe and successful use of a corresponding medicine or biological product. The test aids a physician in determining if the benefits of a medicinal product to patients will outweigh any potential serious side effects or hazards. Patients who are most likely to benefit from a certain medicinal product can be identified using companion diagnostics. A companion diagnostic (CDx) is a medical instrument or test that gives information necessary for the safe and successful use of a biological product; in most cases, this would be a highly personalized or focused medication treatment. It allows a doctor to determine if the advantages of a drug or treatment for a patient outweigh any potential serious side effects or hazards. The companion diagnostic is a pharmacogenomics approach. This refers to how a person's complete genome (i.e., their entire genetic pattern, not just individual genes) reacts to the usage of a drug, as well as the drug's total potential influence on that person, including the drug's potential benefits and risks.
Title : Copper (II) complexes as potential anticancer agents
Salah S Massoud, University of Louisiana, United States
Title : Pharmacogenomics: current status and future directions
Matthias Schwab, University of Tübingen, Germany
Title : Talus bone of the hindfoot: Unique anatomy and an important clinical implication
Abdelmonem Awad Hegazy, Zarqa University, Jordan
Title : The use of anti seizure medication therapeutic blood level determination to personalise the treatment of epileptic seizures especially in patients attending the accident and emergency department
Roy Gary Beran, University of New South Wales, Australia
Title : Effect of Fluvoxamine on Interluekin-6 level of COVID-19 patients, hospitalized in ICU: A randomized clinical trial
Mitra Safa, Shahid Beheshti University of Medical Sciences, Iran (Islamic Republic of)
Title : Precision Treatment of Alzheimer's
Boris Tankhilevich, Magtera, Inc., United States